Franklin Resources Inc Adagio Therapeutics, Inc. Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.54 - $4.52 $2.05 Million - $3.66 Million	-809,053 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.81 - $10.77 $1.18 Million - $3.33 Million	309,039 Added 61.81%	809,053 $3.69 Million
Q3 2021 Nov 12, 2021	BUY	$20.88 - $56.08 $10.4 Million - $28 Million	500,014 New	500,014 $21.1 Million

63.9M

2.3K

2.1K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.